CervoMed
Develops neflamapimod for age-related brain disorders.
$2.56
After-hours close−0.04 (−1.54%)
At close$2.60(−1.52%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.61 | — | — |
| Aug 2026 | −$0.80 | −$0.64 | +19.7% |
| Aug 2026 | −$0.87 | −$0.64 | +26.4% |
| May 2026 | −$0.90 | −$0.86 | +4.4% |
| Mar 2026 | −$0.79 | −$0.88 | −11.4% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Nov 2025 | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Dec 2022 | |||
| Sep 2022 | |||
| Jun 2022 | |||
| Mar 2022 | |||
| Dec 2021 | |||
| Sep 2021 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Dec 2017 | |||
| Sep 2017 | |||
| Jun 2017 | |||
| Mar 2017 | |||
| Dec 2016 | |||
| Sep 2016 | |||
| Jun 2016 | |||
| Mar 2016 | |||
| Dec 2015 | |||
| Sep 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 12, 2026 | −$0.61 | — | — | $50.0K | — | — |
| Aug 10, 2026 | −$0.80 | −$0.64 | +19.7% | $50.0K | — | — |
| Aug 7, 2026 | −$0.87 | −$0.64 | +26.4% | $50.0K | — | — |
| May 18, 2026 | −$0.90 | −$0.86 | +4.4% | $71.4K | — | — |
| Mar 13, 2026 | −$0.79 | −$0.88 | −11.4% | $90.8K | $6.5K | −92.8% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Nov 7, 2025 | ||||||
| Aug 8, 2025 | ||||||
| May 12, 2025 | ||||||
| Mar 17, 2025 | ||||||
| Nov 12, 2024 | ||||||
| Aug 9, 2024 | ||||||
| May 14, 2024 | ||||||
| Mar 25, 2024 | ||||||
| Nov 13, 2023 | ||||||
| Aug 8, 2023 | ||||||
| May 15, 2023 | ||||||
| Dec 31, 2022 | ||||||
| Sep 29, 2022 | ||||||
| Jun 29, 2022 | ||||||
| Mar 30, 2022 | ||||||
| Dec 30, 2021 | ||||||
| Sep 29, 2021 | ||||||
| Jun 30, 2021 | ||||||
| Mar 31, 2021 | ||||||
| Dec 31, 2020 | ||||||
| Sep 30, 2020 | ||||||
| Jun 30, 2020 | ||||||
| Mar 31, 2020 | ||||||
| Dec 31, 2019 | ||||||
| Sep 30, 2019 | ||||||
| Jun 30, 2019 | ||||||
| Mar 31, 2019 | ||||||
| Dec 30, 2018 | ||||||
| Sep 30, 2018 | ||||||
| Jun 30, 2018 | ||||||
| Mar 31, 2018 | ||||||
| Dec 30, 2017 | ||||||
| Sep 30, 2017 | ||||||
| Jun 30, 2017 | ||||||
| Mar 31, 2017 | ||||||
| Dec 30, 2016 | ||||||
| Sep 30, 2016 | ||||||
| Jun 30, 2016 | ||||||
| Mar 31, 2016 | ||||||
| Dec 31, 2015 | ||||||
| Sep 30, 2015 | ||||||